Limitation by p70 S6 kinase of platelet-derived growth factor-BB-induced interleukin 6 synthesis in osteoblast-like MC3T3-E1 cells

Metabolism: Clinical and Experimental

Volumn 56, Issue 4, 2007, Pages 476-483

  Takai, Shinji ^a   Tokuda, Haruhiko ^a,b   Hanai, Yoshiteru ^a,b   Kozawa, Osamu ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; INDOMETACIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PB 98059; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN P70; RAPAMYCIN; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; INTERLEUKIN-6; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIROLIMUS;

EID: 33947282872     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.11.005     Document Type: Article

References (35)

1. Akira S., Taga T., and Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 54 (1993) 1-78
2. Heymann D., and Rousselle A.V. gp130 Cytokine family and bone cells. Cytokine 12 (2000) 1455-1468
3. Kwan Tat S., Padrines M., Theoleyre S., Heymann D., and Fortun Y. IL-6 is produced by osteoblasts and induces bone resorption. Cytokine Growth Factor Rev 15 (2004) 49-60
4. Nijweide P.J., Burger E.H., and Feyen J.H.M. Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev 86 (1986) 855-886
5. Ishimi Y., Miyaura C., Jin C.H., Akatsu T., Abe E., Nakamura Y., et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145 (1990) 3297-3303
6. Roodman G.D. Interleukin-6: an osteotropic factor?. J Bone Miner Res 7 (1992) 475-478
7. Helle M., Brakenhoff J.P.J., DeGroot E.R., and Aarden L.A. Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol 18 (1998) 957-959
8. Littlewood A.J., Russil J., Harvey G.R., Hughes D.E., Russel R.G.G., and Gowen M. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology 129 (1991) 1513-1520
9. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79 (1999) 1283-1316
10. Heldin C.H., Eriksson U., and Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 398 (2002) 284-290
11. Heldin C.H., Johnsson A., Wennergren S., Wernstedt C., Betsholtz C., and Westermark B. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature 319 (1986) 511-514
12. Canalis E., Varghese S., McCarthy T.L., and Centrella M. Role of platelet derived growth factor in bone cell function. Growth Regul 2 (1992) 151-155
13. Kozawa O., Suzuki A., Watanabe Y., Shinoda J., and Oiso Y. Effect of platelet-derived growth factor on phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like cells. Endocrinology 136 (1995) 4473-4478
14. Franchimont N., Durant D., Rydziel S., and Canalis E. Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2. J Biol Chem 274 (1999) 6783-6789
15. Pullen N., and Thomas G. The modular phosphorylation and activation of p70s6k. FEBS Lett 410 (1997) 78-82
16. Susa M., Standke G.J., Jeschke M., and Rohner D. Fluoroaluminate induces pertussis toxin-sensitive protein phosphorylation: differences in MC3T3-E1 osteoblastic and NIH3T3 fibroblastic cells. Biochem Biophys Res Commun 235 (1997) 680-684
17. Kozawa O., Matsuno H., and Uematsu T. Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts. J Cell Biochem 81 (2001) 430-436
18. Tokuda H., Hatakeyama D., Shibata T., Akamatsu S., Oiso Y., and Kozawa O. p38 MAP kinase regulates BMP-4-stimulated VEGF synthesis via p70 S6 kinase in osteoblasts. Am J Physiol Endocrinol Metab 284 (2003) E1202-E1209
19. Sudo H., Kodama H., Amagai Y., Yamamoto S., and Kasai S. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol 96 (1983) 191-198
20. Kozawa O., Tokuda H., Miwa M., Kotoyori J., and Oiso Y. Cross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis induced by prostaglandin E2 in osteoblast-like cells. Exp Cell Res 198 (1992) 130-134
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
22. Kato K., Ito H., Hasegawa K., Inaguma Y., Kozawa O., and Asano T. Modulation of the stress-induced synthesis of hsp27 and alpha B-crystallin by cyclic AMP in C6 rat glioma cells. J Neurochem 66 (1996) 946-950
23. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79 (1999) 143-180
24. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 270 (1995) 27489-27494
25. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364 (1995) 229-233
26. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98 (2001) 13681-13686
27. Watanabe-Tomita Y., Suzuki A., Oiso Y., and Kozawa O. Prostaglandin E1 stimulates interleukin-6 secretion via protein kinase A in osteoblast-like cells. Cell Signal 9 (1997) 105-108
28. Kozawa O., Suzuki A., Tokuda H., and Uematsu T. Prostaglandin F2alpha stimulates interleukin-6 synthesis via activation of PKC in osteoblast-like cells. Am J Physiol 272 (1997) E208-E211
29. Tokuda H., Kozawa O., Harada A., and Uematsu T. Prostaglandin D2 induces interleukin-6 synthesis via Ca2+ mobilization in osteoblasts: regulation by protein kinase C. Prostaglandins Leukot Essent Fatty Acids 61 (1999) 189-194
30. Kozawa O., Suzuki A., Tokuda H., Kaida T., and Uematsu T. Interleukin-6 induced by prostaglandin E2: cross-talk regulation by protein kinase C. Bone 22 (1998) 355-360
31. Smith W.L. The eicosanoids and their biochemical mechanisms of action. Biochem J 259 (1989) 315-324
32. Price D.J., Grove J.R., Calvo V., Avruch J., and Bierer B.E. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257 (1992) 973-977
33. Kuo C.J., Chung J., Fiorentino D.F., Flanagan W.M., Blenis J., and Crabtree G.R. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358 (1992) 70-73
34. Ducy P., Desbois C., Boyce C., Pinero G., Story B., Dunstan C., et al. Increased bone formation in osteocalcin-deficient mice. Nature 382 (1996) 448-452
35. Canalis E., and Rydziel S. Platelet-derived growth factor and the skeleton. In: Belizikian J., Raisz L.J., and Rodan G. (Eds). Principles of Bone Biology. 2nd ed. (2002), Academic Press, San Diego 817-824